Remdesivir has little effect on hospital stay or mortality in COVID-19 patients, WHO study finds

Gilead Sciences Inc.'s remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization has found.

source https://www.cbc.ca/news/health/remdesivir-covid-19-who-solidarity-trial-1.5764858?cmp=rss